Boston, MA · Founded 2019 · Privately Held (backing)
Developer of transdermal drug delivery technology designed to reformulate clinically validated molecules into needle-free therapeutics for chronic diseases. Anodyne Nanotech is based in Boston, MA and was founded in 2019. Its last reported valuation was $7 million in Aug 2020. It has raised $9.6 million across 3 recorded rounds; the latest was a $12.6 million early-stage round in May 2026.
Last reported valuation
$7.0M
Oct 2026
Priced at
—
Total raised
$9.6M
Last round
Early Stage VC
May 2026
No prints on record
No secondary trades in Anodyne Nanotech shares have been recorded yet. When market activity lands it appears here as monthly aggregates and, for platform-recorded trades, dated prints.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Anodyne Nanotech with a free account
·Watch Anodyne Nanotech: the Monday email on marks, rounds and moves
Secondary marks are indicative month-end price levels observed across secondary-market trading venues — a level, not a trade — and are the market input to the PrivateMarketView mark. Private share prices aren’t published anywhere. Aggregate figures combine multiple reporting channels — direct participant reports, platform transactions, third-party market intelligence — at monthly granularity. Individually dated prints are a Pro feature and are shown only for transactions recorded on our own platform. Third-party-reported trades are never republished individually, at any tier. Verified prints (✓) have been confirmed against a second source. Prints marked SPV or Forward reflect the structure’s pricing, which can differ from direct share transfers of Anodyne Nanotech stock.
